Entering text into the input field will update the search result below

Paratek and ResMed price targets raised, Orphazyme downgraded; in today’s analyst action

Wall Street sign post with green line chart diagram indicating stock market going up. In the background blurred American US flags hanging from buildings
Ole Schwander/iStock via Getty Images

Orphazyme cut to sell at Guggenheim after regulatory snub

  • Orphazyme (NASDAQ:ORPH) is trading ~3.4% higher in the pre-market today after losing more than 50% on Friday in reaction to its failure to win

Recommended For You

Related Stocks

SymbolLast Price% Chg
RMD--
ResMed Inc.
PRTK--
Paratek Pharmaceuticals, Inc.
AMN--
AMN Healthcare Services, Inc.
RCUS--
Arcus Biosciences, Inc.